grantGrants.gov

Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)

Organization National Institutes of HealthPosted 21 Nov 2024Deadline 4 May 2026
HHS-NIH1193.39493.395synopsis
Sign up free to applyFree account · Full description · Apply link · All opportunity types

Full Description

Opportunity Number: PAR-25-106 Document Type: synopsis CFDA Numbers: 93.394, 93.395

Read the full description

Sign up freeFree account · No credit card required
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) — National Institutes of Health | Dev Procure